Orthofix Medical (FRA:OM2) Total Liabilities: €385.3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OM2 Orthofix Medical Inc FRA:OM2
60 GF Score
Price €8.70
GF Value €12.11
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Orthofix Medical Total Liabilities?

Orthofix Medical FRA:OM2 +1.75% 60 Total Liabilities is €385.3 Mil as of Jun. 2026. GuruFocus rates FRA:OM2 with a GF Score™ of 60/100 and a GF Value™ of €12.11 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Orthofix Medical's Total Liabilities for the quarter that ended in Jun. 2026 was €385.3 Mil.

Orthofix Medical's quarterly Total Liabilities increased from Dec. 2025 (€342.12 Mil) to Mar. 2026 (€390.47 Mil) but then declined from Mar. 2026 (€390.47 Mil) to Jun. 2026 (€385.25 Mil).

Orthofix Medical's annual Total Liabilities increased from Dec. 2023 (€299.48 Mil) to Dec. 2024 (€372.61 Mil) but then declined from Dec. 2024 (€372.61 Mil) to Dec. 2025 (€342.12 Mil).

Orthofix Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for Orthofix Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orthofix Medical Total Liabilities Chart

Orthofix Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123.63 114.95 299.48 372.61 342.12

Orthofix Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 328.43 332.39 342.12 390.47 385.25
FRA:OM2
60GF Score
Orthofix Medical Inc FRA:OM2
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orthofix Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Orthofix Medical's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=145.592+(148.981+47.548
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=342.1

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=726.453-384.332
=342.1

Orthofix Medical's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=136.285+(203.541+45.427
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=385.3

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=757.781-372.528
=385.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €385.3 Mil mean?
Orthofix Medical (FRA:OM2) has a Total Liabilities of €385.3 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Orthofix Medical and its competitors.
Is Orthofix Medical's Total Liabilities too high?
Orthofix Medical's current Total Liabilities is €385.3 Mil. Overall, Orthofix Medical has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Total Liabilities compare to VMD and VREX?
Orthofix Medical's Total Liabilities of €385.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Orthofix Medical and its competitors. Orthofix Medical's current Total Liabilities is €385.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (FRA:OM2) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.11, compared to a current price of €8.70 — trading 28.2% below its estimated fair value. The current Total Liabilities is €385.3 Mil. Orthofix Medical's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Orthofix Medical (FRA:OM2), the current Total Liabilities is €385.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orthofix Medical (FRA:OM2) Overvalued in 2026?

Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued. The current stock price of €8.70 is trading 28.2% below its estimated GF Value™ of €12.11. GuruFocus considers Orthofix Medical to be Modestly Undervalued.

Key valuation signals for FRA:OM2:

  • Total Liabilities: €385.3 Mil
  • GF Value™: €12.11 vs. price of €8.70 (28.2% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the FRA:OM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orthofix Medical Business Description

Other Exchanges OFIX:USA
Address 3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
60GF Score

Get the complete analysis for FRA:OM2

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.70
Price
€12.11
GF Value